by Mikal C. Watts on 12/03/2012
According to DrugCite, a respected website that puts out information synthesized from the FDA Adverse Event Reporting System (FAERS), gastrointestinal bleeds remain the most common adverse event reported by users of the blood thinner Pradaxa. This is not news to our firm, as we have closely monitored the dangers of this medication for well over a year now. Unfortunately, our firm continues to see new cases in which Pradaxa users took this medication and then suffered an irreversible bleeding event, and many of these events have been GI bleeds.
While there could be a variety of reasons for the large number of stomach bleeds, many believe that the acidic or tartaric acid core of the Pradaxa pill is simply too strong for users' stomachs. The strongly acidic innards of the blood thinner wreak havoc on the gastrointestinal system, and allow for a rapid absorption of the medication. The delicate GI tract suffers injury while the body is doused in anti-coagulant at a rapid pace, and this combination seems to have contributed to the over 2,000 GI bleeds reported so far to the FDA.
Our firm, Watts Guerra, filed the first Pradaxa cases in the country, moved to consolidate the Pradaxa litigation in the Southern District of Illinois, and now I serve as Co-Lead Counsel for the nationally consolidated Pradaxa Multidistrict Litigation proceedings. We are serious about this litigation and we are honored to help side effects victims and families who have lost loved ones.blog comments powered by Disqus